What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Biochemistry, EIF4E, Molecular biology, Cell biology and Initiation factor.
His research on EIF4E frequently links to adjacent areas such as Eukaryotic translation.
His work carried out in the field of Molecular biology brings together such families of science as Von Hippel–Lindau tumor suppressor, Tumor suppressor gene, Transcription factor and Transcription.
His Cell biology study integrates concerns from other disciplines, such as Translation, Translational regulation, EIF4G and Protein biosynthesis.
His Initiation factor research is multidisciplinary, relying on both Eukaryotic translation initiation factor 4 gamma, Internal ribosome entry site and Eukaryotic initiation factor.
Arnim Pause interconnects Eukaryotic initiation factor 4F, eIF2 and Translation factor in the investigation of issues within Eukaryotic translation initiation factor 4 gamma.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function (1094 citations)
- PHAS-I as a link between mitogen-activated protein kinase and translation initiation. (610 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Cell biology, Molecular biology, Biochemistry, AMPK and Virology.
His studies in Cell biology integrate themes in fields like Translation, EIF4E, TFEB and Protein biosynthesis.
His research integrates issues of Eukaryotic translation, Binding protein and Eukaryotic initiation factor in his study of EIF4E.
His Eukaryotic initiation factor research includes elements of Eukaryotic initiation factor 4F, Internal ribosome entry site, EIF4G and Initiation factor.
The various areas that Arnim Pause examines in his Molecular biology study include Von Hippel–Lindau tumor suppressor, Protein phosphatase 2, RNA-dependent RNA polymerase, Transcription and Protein tyrosine phosphatase.
His Virology research incorporates themes from RNA and Drug discovery.
He most often published in these fields:
- Cell biology (58.70%)
- Molecular biology (21.74%)
- Biochemistry (27.17%)
What were the highlights of his more recent work (between 2017-2021)?
- Cell biology (58.70%)
- TFEB (7.61%)
- AMPK (14.13%)
In recent papers he was focusing on the following fields of study:
Arnim Pause focuses on Cell biology, TFEB, AMPK, mTORC1 and Folliculin.
Arnim Pause has included themes like Cancer, Cell surface receptor and ESCRT in his Cell biology study.
His Cancer cell study in the realm of Cancer connects with subjects such as Programmed cell death.
The study incorporates disciplines such as ULK1, Cancer research, Nuclear localization sequence, Phosphorylation and Regulator in addition to TFEB.
His AMPK study combines topics in areas such as Agonist, Endocrinology, Glycogen branching enzyme and Carbohydrate.
His Protein kinase A study improves the overall literature in Biochemistry.
Between 2017 and 2021, his most popular works were:
- mTOR Pathways in Cancer and Autophagy. (128 citations)
- The Transcription Factors TFEB and TFE3 Link the FLCN-AMPK Signaling Axis to Innate Immune Response and Pathogen Resistance. (39 citations)
- The AMPK agonist 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation‐associated cachectic muscle wasting (29 citations)
In his most recent research, the most cited papers focused on:
Arnim Pause spends much of his time researching Cell biology, TFEB, AMPK, Cancer and Lysosome.
Arnim Pause interconnects Stress granule, Plasminogen activator and Fight-or-flight response in the investigation of issues within Cell biology.
The TFEB study combines topics in areas such as Phenotype, Innate immune system, Folliculin and Protein kinase A.
His AMPK study integrates concerns from other disciplines, such as Internal medicine, Atrophy, Anaerobic glycolysis, Cachexia and Mitochondrion.
His study in the fields of Cancer cell under the domain of Cancer overlaps with other disciplines such as Programmed cell death.
While working in this field, Arnim Pause studies both Programmed cell death and Cell signaling.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
